HER-2阳性转移性乳腺癌脑转移进展后继续使用曲妥珠单抗的临床效用 - Suppr

Suppr

超能文献

Clinical utility of continuing trastuzumab beyond brain progression in HER-2 positive metastatic breast cancer.

作者信息

Metro Giulio, Sperduti Isabella, Russillo Michelangelo, Milella Michele, Cognetti Francesco, Fabi Alessandra

出版信息

Oncologist. 2007 Dec;12(12):1467-9; author reply 1469-71. doi: 10.1634/theoncologist.12-12-1467.

DOI:10.1634/theoncologist.12-12-1467

PMID:18165625

Abstract

摘要

相似文献

Clinical utility of continuing trastuzumab beyond brain progression in HER-2 positive metastatic breast cancer.

Oncologist. 2007 Dec;12(12):1467-9; author reply 1469-71. doi: 10.1634/theoncologist.12-12-1467.

Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies.

Breast Cancer Res. 2005;7(4):R436-43. doi: 10.1186/bcr1020. Epub 2005 Apr 8.

Extended survival in women with brain metastases from HER2 overexpressing breast cancer.

Am J Clin Oncol. 2008 Jun;31(3):250-4. doi: 10.1097/COC.0b013e31815a43c4.

Survival after brain metastases from breast cancer in the trastuzumab era.

J Clin Oncol. 2005 Mar 20;23(9):2114-6; author reply 2116-7. doi: 10.1200/JCO.2005.05.249.

Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab.

Cancer Chemother Pharmacol. 2009 May;63(6):1157-9. doi: 10.1007/s00280-008-0859-7. Epub 2008 Nov 6.

Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer.

Breast. 2006 Apr;15(2):219-25. doi: 10.1016/j.breast.2005.04.017. Epub 2005 Jul 18.

Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab.

Acta Oncol. 2006;45(2):196-201. doi: 10.1080/02841860500486630.

Beyond HER2 and trastuzumab: heterogeneity, systems biology, and cancer origin research may guide the future for personalized treatment of very early but aggressive breast cancer.

J Clin Oncol. 2010 Jun 10;28(17):e279-80; author reply e282-3. doi: 10.1200/JCO.2009.27.7061. Epub 2010 Apr 20.

Trastuzumab.

Cancer Treat Res. 2009;151:181-96. doi: 10.1007/978-0-387-75115-3_12.

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

Cancer. 2003 Jun 15;97(12):2972-7. doi: 10.1002/cncr.11436.

引用本文的文献

An exploration of the clinical progression models of osimertinib in the treatment of advanced EGFR-mutant non-small cell lung cancer.

Transl Lung Cancer Res. 2022 May;11(5):817-831. doi: 10.21037/tlcr-22-315.

Incidence of central nervous system metastases in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with trastuzumab: A meta-analysis.

Clinics (Sao Paulo). 2021 Aug 16;76:e2653. doi: 10.6061/clinics/2021/e2653. eCollection 2021.

HER2-targeted therapy prolongs survival in patients with HER2-positive breast cancer and intracranial metastatic disease: a systematic review and meta-analysis.

Neurooncol Adv. 2020 Oct 14;2(1):vdaa136. doi: 10.1093/noajnl/vdaa136. eCollection 2020 Jan-Dec.

First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?

J Exp Clin Cancer Res. 2016 Jun 30;35:104. doi: 10.1186/s13046-016-0380-5.

Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema.

Neuro Oncol. 2014 Jul;16(7):1006-9. doi: 10.1093/neuonc/not329.

Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer.

J Thorac Oncol. 2012 Dec;7(12):1807-1814. doi: 10.1097/JTO.0b013e3182745948.

Correlation between quantitative HER-2 protein expression and risk for brain metastases in HER-2+ advanced breast cancer patients receiving trastuzumab-containing therapy.

Oncologist. 2012;17(1):26-35. doi: 10.1634/theoncologist.2011-0212. Epub 2012 Jan 10.

Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier.

MAbs. 2011 Mar-Apr;3(2):153-60. doi: 10.4161/mabs.3.2.14239. Epub 2011 Mar 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验